SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Paint The Table
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jorj X Mckie who wrote (7994)1/2/2002 3:59:47 PM
From: Libbyt  Read Replies (1) of 23786
 
a change in policy that focuses on prescribing generics almost exclusively

I'm sure that the HMOs would want that kind of policy. I'm just not sure how many physicians feel very strongly about certain "name brand" drugs versus the generic drug. I may be wrong, but I think there are a few specific prescriptions that physicians don't want to see substituted with generic drugs because from their experience they've obtained better results using the specific drug prescribed. Some prescription pads used by physicians have a place on the form to check that the generic brand may not be substituted.

Patients also seem to be more programmed to request specific name brand drugs now that prescription drugs are being advertised on T.V. and in magazines.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News